STIFEL FINANCIAL CORP - SQZ BIOTECHNOLOGIES CO ownership

SQZ BIOTECHNOLOGIES CO's ticker is SQZ and the CUSIP is 78472W104. A total of 5 filers reported holding SQZ BIOTECHNOLOGIES CO in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STIFEL FINANCIAL CORP ownership history of SQZ BIOTECHNOLOGIES CO
ValueSharesWeighting
Q2 2023$229,911
-53.0%
851,520
-2.6%
0.00%
-100.0%
Q1 2023$489,622
-36.1%
874,326
-15.6%
0.00%0.0%
Q4 2022$766,313
-31.5%
1,035,558
+111.2%
0.00%
-50.0%
Q3 2022$1,118,000
-24.4%
490,206
+5.4%
0.00%0.0%
Q2 2022$1,479,000
+75.7%
465,032
+165.8%
0.00%
+100.0%
Q1 2022$842,000174,9690.00%
Other shareholders
SQZ BIOTECHNOLOGIES CO shareholders Q3 2023
NameSharesValueWeighting ↓
Artal Group S.A. 1,606,309$9000.05%
Sandy Cove Advisors, LLC 51,707$28,9560.02%
MAVERICK CAPITAL LTD 1,051,771$588,9920.02%
Temasek Holdings (Private) Ltd 2,758,169$1,544,5750.01%
AMERICAN INTERNATIONAL GROUP, INC. 2,517,173$1,409,6170.01%
RBF Capital, LLC 74,674$41,8170.00%
Laurion Capital Management LP 431,400$241,5840.00%
Virtu Financial LLC 17,075$100.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 65,800$36,8480.00%
Bangor Savings Bank 11,357$6,3600.00%
View complete list of SQZ BIOTECHNOLOGIES CO shareholders